CEO of Seven Bridges Genomics, USA
William Moss is a seasoned executive with a proven track record of leading emerging insurtech and health science technology organizations to achieve long-term operational objectives and corporate valuations that exceed team member, industry and investor expectations. In his time at Seven Bridges, Moss has been instrumental in facilitating the development of the company’s newly honed biopharma corporate strategy. He was ranked #14 in the Healthcare Technology Report’s Top 50 Healthcare CEO’s 2020. Prior to Seven Bridges, Moss led the transformation of companies such as MFX USA, Delphi Technology and AMS/Towerstreet, in various lead executive roles.
14:30 - 15:30
Academia session: Biotechnology - How is it shaping our future?
Moderator and chair of the session: Dr. Jelena Begović, Director of Institute of Molecular Genetics and Genetic Engineering (IMGGE) and Full Research Professor
Business session: Accelerating innovation
Moderator and chair of the session: Prof. Robert C. Wolcott, Co-Founder and Chairman of The World Innovation Network (TWIN) and Adjunct Professor of Innovation at Booth School of Business at University of Chicago & Kellogg School of Management at Northwestern University